D-0628-2026 Class II Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0628-2026 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jun 17, 2026 and is designated Class II. Reason for recall: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets. The recall status is ongoing. Affected quantity: 3,456 30-count bottles.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
Jun 17, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,456 30-count bottles

Product description

Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6

Reason for recall

Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

Distribution pattern

Nationwide in the USA

Code information

Lot AE01763, Expires 9/30/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0628-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0628-2026. Report a data issue: hello@regdatalab.com.